1 etwork level, exogenous NEU exerted powerful anticonvulsive action both in vitro and in acute and chr

2         Valproic acid (VPA) is a widely used anticonvulsive agent that has profound antiproliferative

3 the efficacy and safety of three intravenous anticonvulsive agents - levetiracetam, fosphenytoin, and

4 ers - could help the identification of novel anticonvulsive and neuroprotective targets.

5  prevented with selective antidepressant and anticonvulsive drug treatments.

6 third of affected patients do not respond to anticonvulsive drugs that target neurons or neuronal cir

7 ibition has an anti-epileptogenic, or merely anticonvulsive effect.

8  suggests that the mechanisms underlying its anticonvulsive effects differ from those targeted by con

9 istered morphine can have both convulsive or anticonvulsive effects, depending on the dose and specie

10 sedative-locomotor inhibition as well as the anticonvulsive effects, of two distinct BZ-site ligands,

11 s epilepticus and during epilepsy has potent anticonvulsive effects, suggesting that P2Y(1) may be a

12                       Compound 17b displayed anticonvulsive properties inferring a role of mGAT2 in e

13            In addition, IRAP ligands display anticonvulsive properties.

14 1) receptor mediates either proconvulsive or anticonvulsive responses, dependent on the time point of

15 izures, switching from a proconvulsive to an anticonvulsive role depending on physiopathological cont

16 , amnesia, cardiorespiratory depression, and anticonvulsive tolerance.

17 n contrast, succinimide analogs that are not anticonvulsive were relatively poor blockers.